Sera Prognostics
Diagnostic to predict risk of preterm birth

Sera Prognostics is developing diagnostic tests that use proprietary biomarkers that are predictive of preterm birth, preeclampsia and other pregnancy complications. Sera aims to improve the health and development of children through early assessment of pregnancy complications that can guide medical interventions and lead to healthier deliveries.


University
Brigham Young University
University of Utah
Sector
Life Science
Status
Active
Initial Investment Stage
Early
View Website